311 related articles for article (PubMed ID: 3388991)
21. [Determination of IgM-RF, IgA-RF, IgG-RF, IL-1RI, CDK2 and ROC evaluation in patients with rheumatoid arthritis].
Xu N; Huang XZ; Xu LY; Zhuang JH
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1609-11. PubMed ID: 19726306
[TBL] [Abstract][Full Text] [Related]
22. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
[TBL] [Abstract][Full Text] [Related]
23. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
[TBL] [Abstract][Full Text] [Related]
24. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.
Tani Y; Tiwana H; Hukuda S; Nishioka J; Fielder M; Wilson C; Bansal S; Ebringer A
J Rheumatol; 1997 Jan; 24(1):109-14. PubMed ID: 9002020
[TBL] [Abstract][Full Text] [Related]
25. IgM rheumatoid factors react with human class I HLA molecules.
Williams RC; Malone CC; Kao KJ
J Immunol; 1996 Feb; 156(4):1684-94. PubMed ID: 8568276
[TBL] [Abstract][Full Text] [Related]
26. [Rheumatoid factor in rheumatoid arthritis in old age].
Vencovský J
Cas Lek Cesk; 1991 Jan; 130(4):108-11. PubMed ID: 2004398
[TBL] [Abstract][Full Text] [Related]
27. IgG rheumatoid factors against the four human Fc-gamma subclasses in early rheumatoid arthritis (the Swedish TIRA project).
Kanmert D; Kastbom A; Almroth G; Skogh T; Enander K; Wetterö J
Scand J Immunol; 2012 Jan; 75(1):115-9. PubMed ID: 21916920
[TBL] [Abstract][Full Text] [Related]
28. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ
Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
[TBL] [Abstract][Full Text] [Related]
29. [Serum immunoglobulin patterns in rheumatoid arthritis].
Dreher R
Z Rheumatol; 1977; 36(1-2):3-21. PubMed ID: 842145
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of IgM-, IgA- and IgG-rheumatoid factors in seronegative polyarticular disease compared to pauciarticular disease in juvenile chronic arthritis as measured by ELISA.
Varbanova BB; Baleva M; Nikolov K; Mihailova D
Adv Exp Med Biol; 1999; 455():61-8. PubMed ID: 10599324
[TBL] [Abstract][Full Text] [Related]
31. Increased responsiveness of rheumatoid factor-producing B cells in seronegative and seropositive rheumatoid arthritis.
He X; Zhong W; McCarthy TG; Weyand CM; Goronzy JJ
Arthritis Rheum; 1996 Sep; 39(9):1499-506. PubMed ID: 8814061
[TBL] [Abstract][Full Text] [Related]
32. Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis.
Tamura N; Kobayashi S; Kato K; Bando H; Haruta K; Oyanagi M; Kuriyama M; Kipps TJ; Hashimoto H
J Rheumatol; 2001 Dec; 28(12):2583-90. PubMed ID: 11764201
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.
Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ
Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712
[TBL] [Abstract][Full Text] [Related]
34. [Clinical significance of rheumatoid factor--its complement activating property and isotype].
Masuda M; Ota T; Suzuki H; Eto S
Ryumachi; 1992 Aug; 32(4):283-91. PubMed ID: 1411790
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the rheumatoid factors of the IgG, IgM and IgA isotypes as prognostic parameters for rheumatoid arthritis among Iraqi patients.
Ahmed MM; Obaid Al-Ruhaimi KA; Mohammed SH
Indian J Pathol Microbiol; 2010; 53(3):433-8. PubMed ID: 20699498
[TBL] [Abstract][Full Text] [Related]
36. [A solid-phase ELISA with specificity for rheumatoid factors of classes IgA, IgG and IgM].
Lemm G; Hohendahl J; Warnatz H
Immun Infekt; 1984 Oct; 12(5):239-44. PubMed ID: 6389322
[TBL] [Abstract][Full Text] [Related]
37. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
[TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of IgM rheumatoid factor binding to chimeric IgG.
Artandi SE; Canfield SM; Tao MH; Calame KL; Morrison SL; Bonagura VR
J Immunol; 1991 Jan; 146(2):603-10. PubMed ID: 1702808
[TBL] [Abstract][Full Text] [Related]
39. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to denatured type II collagen in rheumatoid arthritis: negative association with IgM rheumatoid factor.
Ferris J; Cooper S; Roessner K; Hochberg M
J Rheumatol; 1990 Jul; 17(7):880-4. PubMed ID: 2213752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
